Clinical Trials Browser

Phase 1/2 × Advanced Lung Cancer × 90 days × Clear all

NCT07367529 2026-05-05

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

Phase 1/2 Recruiting

Advanced Lung Cancer